Dear PBPS Members, Colleagues, and Friends,
November is Pancreatic Cancer Awareness Month, a time to raise awareness of one of the most devastating malignancies affecting patients worldwide and to reaffirm our collective commitment to improving outcomes for those impacted by this disease. As pathologists, clinicians, scientists, trainees, patients, advocates, and caregivers, we share a common goal: advancing early detection, diagnosis, and treatment of pancreatic cancer through research, innovation, education, and collaboration.
Despite significant progress in surgical oncology, systemic therapies, molecular pathology, and biomarker discovery, pancreatic cancer remains a major global health challenge. It continues to be one of the leading causes of cancer-related mortality worldwide. Early detection remains difficult, as many patients present with advanced disease when treatment options are limited and outcomes remain poor. These realities underscore the urgent need for greater public awareness, increased research investment, improved screening and diagnostic approaches, and the development of more effective therapies.
In this effort, the role of pathologists has never been more important. Through accurate histopathologic evaluation, integration of molecular and genomic findings, identification of emerging biomarkers, and participation in multidisciplinary patient care, pathologists play a central role in guiding clinical management and advancing precision medicine. Pathology-driven research continues to improve our understanding of pancreatic cancer biology and to identify new opportunities for earlier detection and therapeutic intervention.
The Pancreatobiliary Pathology Society (PBPS) remains deeply committed to supporting these efforts. Through educational programs, international collaborations, research initiatives, mentorship opportunities, and scientific exchange, PBPS strives to advance knowledge and foster innovations that improve the care of patients with pancreatic cancer and other pancreatobiliary diseases. Our strength lies in our diverse and global membership, united by a shared commitment to excellence in pathology and patient care. By bringing together experts from different disciplines, institutions, and regions of the world, we enhance our ability to address the complex challenges posed by pancreatic cancer and accelerate progress toward better patient outcomes.
Pancreatic Cancer Awareness Month also reminds us of the importance of advocacy and community engagement. Raising awareness helps educate the public about pancreatic cancer, highlights the need for continued research and funding, and supports patients and families navigating the challenges of this disease.
As we observe Pancreatic Cancer Awareness Month, let us reaffirm our dedication to advancing research, improving diagnostic accuracy, mentoring the next generation of pathologists, and strengthening multidisciplinary and international collaborations. Together, we can continue to expand our understanding of pancreatic cancer and translate scientific discoveries into meaningful benefits for patients and their families.
On behalf of the PBPS Executive Committee, thank you for your continued contributions to our society and to the patients we serve. Through scientific discovery, education, collaboration, advocacy, and innovation, we can continue to advance the field of pancreatobiliary pathology and contribute to the fight against pancreatic cancer.
Sincerely,
Huamin Wang, MD, PhD
President
Pancreatobiliary Pathology Society (PBPS)




You must be logged in to post a comment.